Cerebrospinal fluid somatostatin in West syndrome: changes in response to combined treatment with high-dose pyridoxal phosphate and low-dose corticotropin
- 1 December 1998
- journal article
- clinical trial
- Published by Elsevier in Neuropeptides
- Vol. 32 (6) , 581-586
- https://doi.org/10.1016/s0143-4179(98)90089-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Combination Therapy of Infantile Spasms With High-Dose Pyridoxal Phosphate and Low-Dose CorticotropinJournal of Child Neurology, 1996
- Somatostatin, neuropeptide Y, neurokinin B and cholecystokinin immunoreactivity in two chronic models of temporal lobe epilepsyNeuroscience, 1995
- Somatostatin and epilepsyMetabolism, 1990
- Somatostatin, neuropeptide Y, GABA and cholinergic enzymes in brain of pentylenetetrazol-kindled ratsNeuropeptides, 1989
- Cerebrospinal Fluid Somatostatin and Neuropeptide YArchives of Neurology, 1988
- Decreased Hippocampal Inhibition and a Selective Loss of Interneurons in Experimental EpilepsyScience, 1987
- Treatment of the west syndrome with high-dose pyridoxal phosphateBrain & Development, 1987
- Human cerebrospinal fluid somatostatin in neurologic diseaseJournal of the Neurological Sciences, 1985
- Regional distribution of somatostatin-like immunoreactivity in the human brainBrain Research, 1981
- Radioimmunoassay of somatostatinMetabolism, 1978